Your browser doesn't support javascript.
loading
CircRTN4 aggravates mesangial cell dysfunction by activating the miR-513a-5p/FN axis in lupus nephritis.
Miao, Xinyan; Tian, Yuexin; Wu, Lunbi; Zhao, Hang; Liu, Jinxi; Gao, Fan; Zhang, Wei; Liu, Qingjuan; Guo, Huifang; Yang, Lin; Yang, Ran; Feng, Xiaojuan; Liu, Shuxia.
Afiliação
  • Miao X; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Tian Y; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Wu L; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Zhao H; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Liu J; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Gao F; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Zhang W; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Liu Q; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China.
  • Guo H; Department of Rheumatology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Yang L; Department of Nephrology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Yang R; Department of Pathology, Hebei Province Hospital of Chinese Medicine, Shijiazhuang, 050013, China.
  • Feng X; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China. fengxiaojuan1985@163.com.
  • Liu S; Department of Pathology; Center of Metabolic Diseases and Cancer Research, Institute of Medical and Health Science, Hebei Medical University; Key Laboratory of Kidney Diseases of Hebei Province, Shijiazhuang, 050017, China. shuxialiu@hebmu.edu.cn.
Lab Invest ; 102(9): 966-978, 2022 09.
Article em En | MEDLINE | ID: mdl-35523949

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / MicroRNAs Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nefrite Lúpica / MicroRNAs Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article